Standard Glass Lining Technology Limited (SGLTL) has announced that its subsidiary, Standard Scigenics Private Limited, has entered into definitive agreements to acquire the business of Scigenics (India) Private Limited as a going concern on a slump sale basis. The acquisition, valued at Rs 9 crore in cash consideration, was announced on October 31, 2025.

Acquisition Details

The key details of the acquisition are as follows:

About Scigenics India

Scigenics (India) Private Limited, incorporated in December 1991 and based in Tamil Nadu, specializes in manufacturing process equipment and machinery for various industries, including:

• Biotechnology
• Biologics
• Chemical
• Industrial processes

The company's financial performance over the past three years is as follows:

Strategic Implications

The acquisition aims to strengthen Standard Glass Lining Technology's product portfolio and expand its market footprint. This move reflects the company's commitment to growth and innovation in the engineering products sector.

Governance Structure

Post-acquisition, the board structure of Standard Scigenics Private Limited will include:

• 3 directors nominated by Standard Glass Lining Technology Limited
• 2 existing directors from Scigenics India:
  • Mr. Shanmuga Sundaram Muthuswamy as Managing Director
  • Ms. R Nandhini as Director

Regulatory Compliance

The transaction is not classified as a related party transaction and is subject to the fulfillment of conditions precedent as per the definitive agreements. The acquisition is expected to be completed after meeting these conditions.

Standard Glass Lining Technology Limited has made the necessary disclosures to the stock exchanges in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This strategic move by Standard Glass Lining Technology Limited through its subsidiary signals its intent to diversify its product range and strengthen its position in the engineering products market.

Standard Glass Lining Technology Limited (SGLTL) has announced the incorporation of a new subsidiary, Standard Scigenics Private Limited, marking a strategic expansion into specialized manufacturing sectors. The move, disclosed in a regulatory filing, aims to broaden SGLTL's footprint in the production of critical equipment for various high-tech industries.

Key Details of the New Subsidiary

| Aspect | Details | |:----------------------|:---------------------------------------------------------------------------|| | Name | Standard Scigenics Private Limited | | Incorporation Date | September 16, 2025 | | Registered Office | D-12, Phase-I, IDA Jeedimetla, Tirumalagiri, Hyderabad -500055, Telangana | | Authorized Share Capital | Rs. 10.00 lakh | | SGLTL's Shareholding | 51.00% |

Strategic Focus

The newly formed subsidiary will concentrate on designing, developing, assembling, and supplying upstream and downstream process equipment and machinery. Its target industries include:

• Biotechnology
• Biologics
• Chemical
• Pharmaceutical
• Pollution control
• Industrial processes

This diversification is expected to strengthen SGLTL's position in the manufacturing sector, particularly in areas requiring specialized equipment.

Financial and Regulatory Aspects

• The initial capital subscription was made in cash by SGLTL.
• The incorporation does not fall under related party transactions.
• No governmental or regulatory approvals were required for this incorporation.

Market Implications

The establishment of Standard Scigenics Private Limited could potentially open new revenue streams for SGLTL. By entering into the manufacturing of specialized equipment for biotechnology and pharmaceutical industries, among others, SGLTL is positioning itself to benefit from the growth in these sectors.

Investors and market watchers will likely keep a close eye on how this new subsidiary impacts SGLTL's overall business strategy and financial performance in the coming quarters.